Rolling Out3d
These new remedies works better in pain management
Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...
Rheumatology Advisor2d
FDA Fast Tracks Investigational Nonopioid Treatment for Acute Pain
The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.
Tariffs won't decrease fentanyl deaths. Treatment and prevention efforts will | Opinion
Don’t fall for the distraction of tariffs. To reduce fentanyl deaths, we need to get opioid users into treatment and reduce ...
Business Wire6d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Trea…
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
Worldwide study finds high rates of depression and anxiety in people with chronic pain
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of ...
Clinical Trials Arena on MSN5d
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
The company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
The 9 Best Pillows For Shoulder Pain Relief Based On Your Sleep Style
According to joint experts, the best pillows for shoulder pain depend on sleep style, loft, fill and more. See our top 9 ...
BioPharma Dive5d
Vertex’s new pain drug gets first coverage nod from major insurer
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...